This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYMUS_EXALLC for full statistics.
Malignant neoplasm of thymus
C3_THYMUS
thymus neoplasm: A neoplasm that affects the thymus. Representative examples include thymoma and carcinoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
112 |
4. Check minimum number of eventsNone |
112 |
5. Include endpointsNone |
112 |
6. Filter based on genotype QC (FinnGen only) |
112 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of thymus
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 112 | 51 | 61 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 60.78 | 58.59 | 62.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 99
- Matched controls
- 989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
+∞
52.9
46
*
C37
ICD-10 Finland
Malignant neoplasm of thymus
+∞
46.6
41
*
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
+∞
45.3
40
*
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
+∞
44.1
39
*
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
32.0
29
*
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
+∞
32.0
29
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
32.9
29.6
39
19
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
13.3
23.5
45
58
GEC23
NOMESCO Finland
Transsternal thymectomy
+∞
20.5
19
*
8582/3-C37.9
ICD-O-3
Thymoma, type AB of thymus
+∞
19.4
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.4
16.1
74
311
WX408
NOMESCO Finland
General anesthesy, balanced
5.8
14.4
53
164
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.7
14.2
36
68
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
13.9
13
*
GD1AD
NOMESCO Finland
Thorax CT examination
12.0
13.5
25
27
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
+∞
12.8
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
21.6
12.6
18
10
N07AA02
ATC
pyridostigmine; systemic
+∞
11.7
11
*
H02AB02
ATC
dexamethasone; systemic
6.9
10.8
28
53
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.1
10.6
20
22
ZXC96
NOMESCO Finland
Robot assisted procedure
15.5
10.6
17
13
108
Kela drug reimbursment
Myasthenia gravis
+∞
10.6
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
33.7
9.6
12
*
130
Kela drug reimbursment
Malignant tumour
7.0
9.5
24
43
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
9.2
36
109
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
11.1
9.2
17
18
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.5
9.2
16
15
R4110
NOMESCO Finland
Physiotherapy
4.1
9.2
43
155
JN4BD
NOMESCO Finland
Extensive body CT
5.5
9.0
28
66
B01AB05
ATC
enoxaparin; parenteral
3.8
8.7
47
189
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
49.0
7.8
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.4
7.8
14
14
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.9
7.8
16
21
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
12.3
7.6
13
12
8585/3-C37.9
ICD-O-3
Thymoma, type B3 of thymus
+∞
7.4
7
*
8583/3-C37.9
ICD-O-3
Thymoma, type B1 of thymus
+∞
7.4
7
*
8581/3-C37.9
ICD-O-3
Thymoma, type A of thymus
+∞
7.4
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.0
7.3
14
16
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.9
6.9
14
18
WF002
NOMESCO Finland
Radical radiotherapy
7.8
6.8
15
22
ZX070
NOMESCO Finland
Intensity modified radiotherapy
13.6
6.8
11
9
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.0
6.7
18
35
JN6AD
NOMESCO Finland
CT of torso and neck
28.7
6.3
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
6.3
22
58
D15.2
ICD-10 Finland
Benign neoplasm: Mediastinum
+∞
6.3
6
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
6.3
6
*
8070/3-C37.9
ICD-O-3
Squamous cell carcinoma, NOS, of thymus
+∞
6.3
6
*
A04AA02
ATC
granisetron; systemic, transdermal
7.6
6.3
14
21
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
6.3
19
43
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
13.7
6.2
10
8
WX402
NOMESCO Finland
General anaesthesia
3.8
6.2
28
94
Z51.5
ICD-10 Finland
Palliative care
8.9
6.0
12
15
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
52
86
10.42
33.73
1.8
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
90
373
8.19
21.52
5.3
7.1
inr
1.0
1.2
3.26
18
129
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
212
5.92
19.99
2.6
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
76
286
6.16
19.71
7.7
5.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
297
5.40
17.07
3.1
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
63
228
5.03
16.39
13.9
6.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
14
10
15.86
15.32
5.4
3.7
nmol/l
4.5
3.7
—
14
10
(3013115) Eosinophils [#/volume] in Blood
91
458
6.26
15.24
9.6
5.8
e9/l
0.1
0.2
4.70
79
413
(3001604) Monocytes [#/volume] in Blood
89
441
5.96
15.15
8.0
5.6
e9/l
0.6
0.6
0.58
77
390
(3013650) Neutrophils [#/volume] in Blood by Automated count
99
537
8.27
15.14
18.3
9.5
e9/l
4.0
4.1
0.23
87
473
(3006315) Basophils [#/volume] in Blood
89
442
5.94
15.08
8.0
5.6
e9/l
0.0
0.0
0.06
77
391
(3019198) Lymphocytes [#/volume] in Blood
90
452
6.05
15.02
8.1
5.6
e9/l
1.7
1.8
0.32
76
408
(40768795) Lymph node Pathology biopsy report
15
13
13.17
14.73
1.1
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
87
445
5.28
13.63
5.3
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
84
426
4.89
13.10
12.3
7.1
mmol/l
1.2
1.2
0.06
75
364
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
59
5.44
11.44
1.1
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
51
5.72
11.33
10.5
7.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
37
114
4.35
11.23
10.8
5.6
mmol/l
104.2
103.5
0.36
37
109
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
12
12
11.08
10.63
3.2
1.7
ug/l
28.0
18.1
0.44
12
12
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
52
5.31
10.09
10.1
5.1
mmol/l
25.4
24.8
0.30
23
52
(3027801) Oxygen [Partial pressure] in Arterial blood
34
107
4.13
9.92
11.6
6.3
kpa
13.9
11.9
0.83
34
102
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
34
107
4.13
9.92
11.6
6.3
kpa
5.4
5.1
1.21
34
101
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
66
325
3.51
9.75
3.6
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
58
265
3.47
9.64
6.2
4.1
ph
7.4
7.4
—
8
52
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
23
7.38
9.61
1.5
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
27
74
4.49
9.40
15.7
6.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
75
407
3.55
9.33
14.9
9.2
e9/l
0.0
0.0
0.23
62
341
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
113
3.88
9.13
1.1
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
68
357
3.30
8.75
2.6
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
140
3.59
8.73
1.6
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
15
26
6.51
8.58
2.3
1.9
%
242.1
179.4
1.56
15
26
(3030467) Casts [#/volume] in Urine by Automated count
54
254
3.17
8.27
3.3
3.0
e6/l
0.2
0.4
1.00
43
183
(36304419) Bacteria [Presence] in Urine
53
247
3.17
8.24
3.3
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
139
3.34
7.57
3.4
2.8
e6/l
2.9
1.7
0.19
23
75
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
186
3.13
7.48
1.8
1.9
mg/l
2.8
2.9
0.10
38
161
(3023368) Bacteria identified in Blood by Culture
52
254
2.95
7.25
5.7
4.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
10
13
8.35
7.24
2.0
1.2
e9/l
0.8
1.4
—
5
5
(3017143) Hepatitis C virus Ab [Presence] in Serum
28
95
3.60
7.16
1.2
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
151
3.17
7.05
3.4
2.7
e6/l
1.9
0.7
0.60
24
86
(3002582) Erythrocytes [#/volume] in Urine
56
289
2.88
7.00
3.3
3.0
e6/l
79.5
35.8
0.42
45
221
(3018095) Leukocytes [#/volume] in Urine
60
323
2.85
6.90
3.9
3.5
e6/l
98.8
27.3
0.46
46
232
(3028026) IgM [Mass/volume] in Serum or Plasma
20
57
4.05
6.51
1.7
1.5
g/l
0.9
1.3
1.11
15
52
(3026782) Osmolality of Urine
38
173
2.81
5.84
1.8
2.7
mosm/kgh2o
590.5
562.2
0.28
33
150
(3003694) ABO and Rh group [Type] in Blood
47
239
2.67
5.83
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
7
13.83
5.68
1.1
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
200
2.66
5.47
2.0
1.7
mg/l
1.4
1.2
0.31
33
161
(3002256) Pathology report gross observation
29
118
2.97
5.43
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
35
164
2.65
5.00
2.6
3.2
ng/l
42.3
138.6
1.22
28
128
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
27
114
2.80
4.69
2.1
2.5
%
23.5
24.4
0.11
27
100
(4010399)
20
71
3.21
4.68
1.5
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
29
128
2.71
4.63
2.2
2.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
20
72
3.16
4.57
2.6
2.9
g/l
66.0
67.1
0.29
20
67
(3037467) Urinalysis macro (dipstick) panel - Urine
85
616
2.58
4.49
3.9
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
25
105
2.78
4.37
1.3
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
104
2.66
3.93
2.3
4.4
ug/l
1.9
12.5
1.49
16
83
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
11
7.73
3.93
1.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
15
6.42
3.90
1.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
15
50
3.31
3.85
1.1
1.3
u/ml
20.3
169.7
—
10
44
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
52
3.18
3.62
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
17
5.65
3.59
1.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
6
10.47
3.54
1.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
15
5.65
3.25
1.0
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
12
39
3.33
3.19
3.8
2.0
u/l
39.4
42.0
0.17
12
32
(3012544) pH of Venous blood
19
82
2.59
3.12
4.2
3.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
8
7.84
3.09
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
14
52
2.93
3.02
6.4
2.4
e9/l
3.8
3.5
0.28
14
41
(40768806) Pleura Pathology biopsy report
6
9
6.97
2.90
1.7
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
95
785
2.38
2.83
37.7
16.1
%
14.2
13.7
1.77
95
777
(40765096) Chromosome analysis panel by Banding
5
6
8.64
2.77
1.0
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
6
8.64
2.77
1.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
6
8.64
2.77
3.2
5.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
32
3.33
2.72
3.1
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
15
4.90
2.64
1.4
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
111
2.22
2.58
1.4
1.4
titre
708.6
475.0
—
7
24
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
26
143
2.07
2.46
1.7
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
83
668
1.94
2.41
4.1
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
53
2.64
2.37
3.0
2.4
ng/l
208.4
102.6
1.06
13
46
(3000492) Spirometry study
19
94
2.23
2.33
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
23
3.66
2.32
1.9
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
23
3.66
2.32
1.1
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
13
4.81
2.30
2.3
3.5
u/ml
21.5
16.9
—
6
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
13
4.81
2.30
2.7
3.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
67
2.43
2.29
2.7
4.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
11
42
2.80
2.26
1.5
2.1
g/l
2.0
1.7
0.35
11
36
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.75
2.23
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
149
1.97
2.19
1.3
1.2
iu/ml
14.7
27.7
—
6
53
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
62
2.44
2.18
1.8
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
62
2.44
2.18
2.9
2.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
14
63
2.40
2.11
6.4
4.5
ng/l
74.0
84.4
0.34
14
57
(3035637) Corticotropin [Mass/volume] in Plasma
5
10
5.17
2.09
3.0
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
10
5.17
2.09
2.4
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
8
26
3.23
2.05
4.5
1.1
g/l
0.0
0.0
—
8
26
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
8
26
3.23
2.05
4.5
1.1
g/l
0.0
0.0
—
8
26
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
16
3.90
1.96
1.5
1.4
—
—
—
0
0
(4268621)
5
11
4.70
1.96
3.2
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
11
4.70
1.96
1.0
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
8
29
2.89
1.83
4.5
1.1
g/l
0.1
0.0
—
8
29
(40761511) CBC panel - Blood by Automated count
106
975
2.63
1.81
23.5
12.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
36
2.63
1.78
4.1
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
18
3.46
1.77
1.8
2.7
u/ml
3.7
3.5
—
6
18
(40760888) Immunoglobulin light chains.free panel - Serum
6
18
3.46
1.77
1.3
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
30
2.79
1.76
2.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
30
2.79
1.76
1.8
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
78
645
1.69
1.75
2.9
3.1
u/l
55.4
55.4
0.00
73
611
(3024928) Oxygen saturation in Venous blood
6
19
3.28
1.68
1.0
2.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
19
3.28
1.68
1.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
25
2.92
1.68
3.1
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
43
2.46
1.65
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
78
2.07
1.63
4.0
3.2
ml/min/173m2
83.1
64.4
—
8
34
(3007164) IgA [Mass/volume] in Serum or Plasma
27
173
1.74
1.60
1.9
1.3
g/l
2.2
2.3
0.07
20
113
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
16
87
1.98
1.55
2.1
2.1
u/l
27.6
34.7
0.69
16
68
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
15
3.44
1.54
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
94
833
1.80
1.47
34.9
13.7
%
39.3
40.7
1.49
72
620
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
16
3.22
1.45
1.4
2.4
%
63.8
63.0
—
5
16
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
16
3.22
1.45
1.4
2.4
e9/l
4.0
5.4
—
5
16
(3009343) pH of Capillary blood
11
53
2.19
1.44
4.2
3.6
—
7.4
—
0
7
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
365
1.55
1.44
4.0
3.5
ng/l
57.6
36.8
0.30
42
254
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
23
2.70
1.38
1.5
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
17
3.03
1.37
1.0
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
18
107
1.81
1.36
2.3
2.5
umol/l
8.8
11.2
0.21
18
95
(1761868) Lipid panel - Serum or Plasma
25
358
0.61
1.34
2.6
2.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
18
2.86
1.30
1.4
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
18
2.86
1.30
1.0
2.0
%
72.0
64.2
—
5
18
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
101
1.81
1.28
1.5
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
37
2.25
1.24
5.4
3.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
19
2.70
1.23
1.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.38
1.20
1.5
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
12
65
1.95
1.18
4.3
6.9
mmol/l
25.4
24.7
0.39
12
60
(3013290) Carbon dioxide [Partial pressure] in Blood
5
20
2.57
1.16
1.6
2.2
kpa
4.9
4.9
—
5
20
(1616796) Gas panel - Central venous blood
5
20
2.57
1.16
1.4
2.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
20
2.57
1.16
1.6
2.2
kpa
8.6
8.7
—
5
20
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
20
2.57
1.16
1.2
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
34
250
1.52
1.15
2.5
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
98
900
1.71
1.06
4.0
4.4
mmol/l
5.7
6.0
1.38
92
830
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
34
2.13
1.05
1.3
1.4
iu/l
48.0
26.3
—
7
34
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
22
2.33
1.04
1.8
1.1
u/l
16.6
5.4
—
5
17
(3036481) Cortisol [Moles/volume] in Serum or Plasma
13
76
1.80
1.04
3.9
2.2
nmol/l
330.2
375.3
0.51
13
69
(3013512) EKG study
33
247
1.48
1.02
3.4
3.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
16
101
1.68
1.00
2.4
2.0
ug/g
141.9
122.3
0.10
16
84
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
38
295
1.44
0.97
3.1
2.7
u/l
65.8
55.5
0.58
38
277
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
94
1.69
0.96
2.6
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
56
467
1.40
0.96
4.2
4.7
estimate
0.0
0.0
0.00
11
87
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
136
1.57
0.95
1.1
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
28
2.21
0.93
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
12
72
1.75
0.89
6.3
5.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
88
947
0.67
0.88
4.1
4.9
mmol/l
2.8
2.8
0.06
83
875
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
16
105
1.61
0.87
1.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.99
0.86
1.7
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
87
935
0.69
0.81
3.6
4.4
mmol/l
4.8
4.7
0.36
82
868
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
24
0.00
0.80
0.0
2.0
—
133.2
—
0
14
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
28
213
1.42
0.79
3.7
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
117
1.53
0.77
1.6
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
23
2.23
0.77
1.6
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
55
471
1.33
0.74
3.0
3.5
estimate
0.0
0.0
0.00
11
82
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
25
2.05
0.73
1.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
150
1.41
0.61
1.2
1.3
u/ml
1.0
6.9
—
5
65
(3019832) Treponema pallidum Ab [Presence] in Serum
10
64
1.62
0.61
2.1
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
74
673
1.29
0.59
3.3
3.7
pmol/l
14.9
14.8
0.08
68
607
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
88
932
0.74
0.57
3.6
4.4
mmol/l
1.4
1.4
0.01
83
858
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
85
904
0.75
0.57
3.2
3.9
mmol/l
1.3
1.3
0.26
80
831
(3020891) Body temperature
6
38
1.61
0.55
2.8
4.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
39
330
1.28
0.55
1.7
1.8
pmol/l
89.5
94.0
0.31
26
159
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
66
1.57
0.54
1.6
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
53
467
1.26
0.53
3.1
3.5
estimate
0.0
0.0
—
10
88
(40761536) Microorganisms panel - Urine sediment
11
76
1.50
0.50
2.0
3.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
47
1.52
0.48
2.1
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
50
1.43
0.46
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
31
1.64
0.43
3.0
3.6
mmol/l
3.9
3.9
—
5
26
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
57
1.43
0.43
1.6
1.3
—
17.9
—
0
5
(3007853) Bacteria identified in Skin by Aerobe culture
15
115
1.35
0.41
1.5
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
54
1.32
0.31
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
316
0.85
0.27
4.3
4.4
%
20.5
22.3
0.40
16
156
(3020682) Albumin/Creatinine [Ratio] in Urine
23
263
0.84
0.25
3.9
4.0
mg/mmol
18.1
9.6
0.40
16
169
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
548.2
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
32.3
—
0
5
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
262.8
—
0
5
(4281824)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
12
0.00
0.21
0.0
4.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
107.1
—
0
14
(3041354) Potassium [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
3.9
—
0
14
(3002523) Influenza virus A Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
50
1.21
0.20
1.0
2.4
%
1.2
1.2
—
6
50
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
8
72
1.12
0.16
4.0
4.0
mmol/l
1.2
1.2
—
8
66
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
119
0.82
0.16
1.7
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
76
0.78
0.16
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
85
0.81
0.15
1.1
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
2.8
3.6
pmol/l
4.0
4.6
—
5
43
(40761535) Cells panel - Urine sediment
8
74
1.09
0.07
6.1
3.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
12
108
1.12
0.07
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
36
375
0.94
0.07
3.2
3.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
23
217
1.08
0.06
6.9
4.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
267
1.06
0.06
2.0
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
59
577
1.05
0.05
2.8
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
25
260
0.95
0.03
3.7
3.6
estimate
0.0
0.0
—
8
83
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
92
1.10
0.03
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
223
1.04
0.01
3.7
2.8
ug/l
0.9
0.7
0.39
17
151
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
116
0.94
0.01
17.3
8.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
105
1.05
0.00
2.5
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.6
—
0.6
—
0
8
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
7.3
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
1.6
—
0
8
(4027681)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
11.2
—
0
7
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
98
0.91
0.00
2.2
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
62
0.97
0.00
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.3
—
91.5
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
304.0
—
0
7
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
4.2
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
6.6
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
176.0
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYMUS – Malignant neoplasm of thymus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).